Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
Agenda & Minutes France Typhoid Ebola Human papillomavirus (HPV)
Download:
meeting agenda Agenda & Minutes United Kingdom Ebola Yellow fever Influenza Tuberculosis Human papillomavirus (HPV)
Download:
NITAG recommendation Recommendation United States of America Diphtheria Tetanus Pertussis
Download:
health policy poliomyelitis Recommendation Indonesia Haemophilus influenzae type B Diphtheria Hepatitis B Tetanus Poliomyelitis Pertussis
Download:
health policy Recommendation Indonesia Haemophilus influenzae type B Diphtheria Hepatitis B Tetanus Pertussis
Download:
health policy poliomyelitis France Diphtheria Tetanus Poliomyelitis Pertussis
Download: